The role of bFGF in down-regulating α-SMA expression of chondrogenically induced BMSCs and preventing the shrinkage of BMSC engineered cartilage

Biomaterials

Volumn 32, Issue 21, 2011, Pages 4773-4781

  Li, Qiong ^a,b   Liu, Tianyi ^a,b   Zhang, Lu ^a,b   Liu, Yu ^a,b   Zhang, Wenjie ^a,b   Liu, Wei ^a,b   Cao, Yilin ^a,b   Zhou, Guangdong ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b National Tissue Engineering Center of China   (China)

Author keywords

Basic fibroblast growth factor (bFGF); Bone marrow stromal cells (BMSCs); Chondrogenesis; Shrinkage; Smooth muscle actin alpha ( SMA)

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIODEGRADABLE SCAFFOLD; BONE MARROW STROMAL CELLS; BONE MARROW STROMAL CELLS (BMSCS); CARTILAGE FORMATION; CARTILAGE REGENERATION; CELL SOURCES; CHONDROGENESIS; CHONDROGENIC; ENGINEERED CARTILAGE; ENGINEERED TISSUES; IN-VITRO; QUALITY IMPROVEMENT; SHAPE CONTROL; SMOOTH MUSCLES; THREE-DIMENSIONAL (3D); TISSUE LEVELS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

BONE; CELL CULTURE; FIBROBLASTS; GENE EXPRESSION; MUSCLE; PEPTIDES; SHRINKAGE; THREE DIMENSIONAL;

CARTILAGE;

ALPHA SMOOTH MUSCLE ACTIN; BASIC FIBROBLAST GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CARTILAGE; CELL SHAPE; CHONDROGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; IN VITRO STUDY; NEWBORN; NONHUMAN; PIGLET; PRIORITY JOURNAL; TISSUE ENGINEERING; UPREGULATION;

ACTINS; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; CARTILAGE; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; CHONDROGENESIS; CULTURE MEDIA; FIBROBLAST GROWTH FACTOR 2; MATERIALS TESTING; STROMAL CELLS; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 79955781071     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.03.020     Document Type: Article

References (37)

1. Mackay A.M., Beck S.C., Murphy J.M., Barry F.P., Chichester C.O., Pittenger M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998, 4(4):415-428.
2. Johnstone B., Hering T.M., Caplan A.I., Goldberg V.M., Yoo J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998, 238(1):265-272.
3. Barry F., Boynton R.E., Liu B., Murphy J.M. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components. Exp Cell Res 2001, 268(2):189-200.
4. Liu K., Zhou G.D., Liu W., Zhang W.J., Cui L., Liu X., et al. The dependence of in vivo stable ectopic chondrogenesis by human mesenchymal stem cells on chondrogenic differentiation in vitro. Biomaterials 2008, 29(14):2183-2192.
5. Kinner B., Spector M. Smooth muscle actin expression by human articular chondrocytes and their contraction of a collagen-glycosaminoglycan matrix in vitro. J Orthop Res 2001, 19(2):233-241.
6. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 2001, 12(9):2730-2741.
7. Akasaka Y., Ono I., Tominaga A., Ishikawa Y., Ito K., Suzuki T., et al. Basic fibroblast growth factor in an artificial dermis promotes apoptosis and inhibits expression of alpha-smooth muscle actin, leading to reduction of wound contraction. Wound Repair Regen 2007, 15(3):378-389.
8. Kurosaka H., Kurosaka D., Kato K., Mashima Y., Tanaka Y. Transforming growth factor-beta 1 p.omotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts. Invest Ophthalmol Vis Sci 1998, 39(5):699-704.
9. Arora P.D., Narani N., McCulloch C.A. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 1999, 154(3):871-882.
10. Narita Y., Yamawaki A., Kagami H., Ueda M., Ueda Y. Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage. Cell Tissue Res 2008, 333(3):449-459.
11. Hellingman C.A., Blaney Davidson E., Koevoet W., Vitters E.L., van den Berg W.B., van Osch G., et al. Smad signaling determines chondrogenic differentiation of bone-marrow derived mesenchymal stem cells: inhibition of Smad 1/5/8P prevents terminal differentiation and calcification. Tissue Eng Part A 2011, [Epub ahead of print].
12. Khouw I.M., van Wachem P.B., Plantinga J.A., Vujaskovic Z., Wissink M.J., de Leij L.F., et al. TGF-beta and bFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro. Biomaterials 1999, 20(19):1815-1822.
13. Zhou G., Liu W., Cui L., Wang X., Liu T., Cao Y. Repair of porcine articular osteochondral defects in non-weightbearing areas with autologous bone marrow stromal cells. Tissue Eng 2006, 12(11):3209-3221.
14. Xu L., Cao D., Liu W., Zhou G., Zhang W.J., Cao Y. In vivo engineering of a efunctional tendon sheath in a hen model. Biomaterials 2010, 31(14):3894-3902.
15. Liu Y., Zhang L., Zhou G., Li Q., Liu W., Yu Z., et al. In vitro engineering of human ear-shaped cartilage assisted with CAD/CAM technology. Biomaterials 2010, 31(8):2176-2183.
16. Liu T.Y., Zhou G.D., Wei X., Wu X.L., Chen F.G., Cui L., et al. [Influence of transforming growth factor-beta1 inducing time on chondrogenesis of bone marrow stromal cells (BMSCs): in vitro experiment with porcine BMSCs]. Zhonghua Yi Xue Za Zhi 2007, 87(31):2218-2222.
17. Wang C., Yin S., Cen L., Liu Q., Liu W., Cao Y., et al. Differentiation of adipose-derived stem cells into contractile smooth muscle cells induced by transforming growth factor-beta1 and bone morphogenetic protein-4. Tissue Eng Part A 2010, 16(4):1201-1213.
18. Zhu J., Li J., Wang B., Zhang W.J., Zhou G., Cao Y., et al. The regulation of phenotype of cultured tenocytes by microgrooved surface structure. Biomaterials 2010, 31(27):6952-6958.
19. Yan D., Zhou G., Zhou X., Liu W., Zhang W.J., Luo X., et al. The impact of low levels of collagen IX and pyridinoline on the mechanical properties of in vitro engineered cartilage. Biomaterials 2009, 30(5):814-821.
20. Alves da Silva M.L., Martins A., Costa-Pinto A.R., Correlo V.M., Sol P., Bhattacharya M., et al. Chondrogenic differentiation of human bone marrow mesenchymal stem cells in chitosan-based scaffolds using a flow-perfusion bioreactor. J Tissue Eng Regen Med 2010, [Epub ahead of print].
21. Park J.S., Yang H.N., Woo D.G., Chung H.M., Park K.H. In vitro and in vivo chondrogenesis of rabbit bone marrow-derived stromal cells in fibrin matrix mixed with growth factor loaded in nanoparticles. Tissue Eng Part A 2009, 15(8):2163-2175.
22. Liu L., Wu W., Tuo X., Geng W., Zhao J., Wei J., et al. Novel strategy to engineer trachea cartilage graft with marrow mesenchymal stem cell macroaggregate and hydrolyzable scaffold. Artif Organs 2010, 34(5):426-433.
23. Worster A.A., Brower-Toland B.D., Fortier L.A., Bent S.J., Williams J., Nixon A.J. Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-beta1 in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res 2001, 19(4):738-749.
24. Narine K., De Wever O., Van Valckenborgh D., Francois K., Bracke M., DeSmet S., et al. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering. Tissue Eng 2006, 12(10):2707-2716.
25. Verbeek M.M., Otte-Holler I., Wesseling P., Ruiter D.J., de Waal R.M. Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. Am J Pathol 1994, 144(2):372-382.
26. Jester J.V., Barry-Lane P.A., Cavanagh H.D., Petroll W.M. Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea 1996, 15(5):505-516.
27. Florini J.R., Ewton D.Z. Actions of transforming growth factor-beta on muscle cells. J Cell Physiol 1988, 135(2):301-308.
28. Pansky A., Roitzheim B., Tobiasch E. Differentiation potential of adult human mesenchymal stem cells. Clin Lab 2007, 53(1-2):81-84.
29. Longobardi L., O'Rear L., Aakula S., Johnstone B., Shimer K., Chytil A., et al. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 2006, 21(4):626-636.
30. Hickok N.J., Haas A.R., Tuan R.S. Regulation of chondrocyte differentiation and maturation. Microsc Res Tech 1998, 43(2):174-190.
31. Tian H., Bharadwaj S., Liu Y., Ma H., Ma P.X., Atala A., et al. Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nano fibrous scaffold for bladder tissue engineering. Biomaterials 2010, 31(5):870-877.
32. Skalli O., Ropraz P., Trzeciak A., Benzonana G., Gillessen D., Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986, 103(6 Pt 2):2787-2796.
33. Sato M., Kawai-Kowase K., Sato H., Oyama Y., Kanai H., Ohyama Y., et al. c-Src and hydrogen peroxide mediate transforming growth factor-beta1-induced smooth muscle cell-gene expression in 10T1/2 cells. Arterioscler Thromb Vasc Biol 2005, 25(2):341-347.
34. Kawai-Kowase K., Sato H., Oyama Y., Kanai H., Sato M., Doi H., et al. Basic fibroblast growth factor antagonizes transforming growth factor-beta1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation. Arterioscler Thromb Vasc Biol 2004, 24(8):1384-1390.
35. Solchaga L.A., Penick K., Porter J.D., Goldberg V.M., Caplan A.I., Welter J.F. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 2005, 203(2):398-409.
36. Carcamo-Orive I., Tejados N., Delgado J., Gaztelumendi A., Otaegui D., Lang V., et al. ERK2 p.otein regulates the proliferation of human mesenchymal stem cells without affecting their mobilization and differentiation potential. Exp Cell Res 2008, 314(8):1777-1788.
37. Frieri M., Capetandes A. The effect of enantiomers of beta-agonists on myofibroblast-derived vascular endothelial growth factor and other matrix components in the presence of dust-mite extract. Allergy Asthma Proc 2008, 29(2):182-188.